-
1
-
-
0035833965
-
Axonal loss in normal-appearing white matter in a patient with acute MS
-
C. Bjartmar, R.P. Kinkel, G. Kidd, R.A. Rudick, and B.D. Trapp Axonal loss in normal-appearing white matter in a patient with acute MS Neurology 57 2001 1248 1252
-
(2001)
Neurology
, vol.57
, pp. 1248-1252
-
-
Bjartmar, C.1
Kinkel, R.P.2
Kidd, G.3
Rudick, R.A.4
Trapp, B.D.5
-
2
-
-
0033773260
-
Association of increased bcl-2 expression with rescue from tumor necrosis factor-alpha-induced cell death in the oligodendrocyte cell line OLN-93
-
G. Burgmaier, L.M. Schonrock, T. Kuhlmann, C. Richter-Landsberg, and W. Brück Association of increased bcl-2 expression with rescue from tumor necrosis factor-alpha-induced cell death in the oligodendrocyte cell line OLN-93 J. Neurochem. 75 2000 2270 2276
-
(2000)
J. Neurochem.
, vol.75
, pp. 2270-2276
-
-
Burgmaier, G.1
Schonrock, L.M.2
Kuhlmann, T.3
Richter-Landsberg, C.4
Brück, W.5
-
3
-
-
0032781891
-
The GABA(B) receptor antagonist CGP 55845A reduces presynaptic GABA(B) actions in neocortical neurons of the rat in vitro
-
R.A. Deisz The GABA(B) receptor antagonist CGP 55845A reduces presynaptic GABA(B) actions in neocortical neurons of the rat in vitro Neuroscience 93 1999 1241 1249
-
(1999)
Neuroscience
, vol.93
, pp. 1241-1249
-
-
Deisz, R.A.1
-
4
-
-
0037085319
-
Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain
-
J. Dörr, I. Bechmann, S. Waiczies, O. Aktas, H. Walczak, P.H. Krammer, R. Nitsch, and F. Zipp Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain J. Neurosci. 22 2002 RC209
-
(2002)
J. Neurosci.
, vol.22
, pp. 209
-
-
Dörr, J.1
Bechmann, I.2
Waiczies, S.3
Aktas, O.4
Walczak, H.5
Krammer, P.H.6
Nitsch, R.7
Zipp, F.8
-
5
-
-
0036147545
-
Induction of TRAIL-mediated glioma cell death by human T cells
-
J. Dörr, S. Waiczies, U. Wendling, B. Seeger, and F. Zipp Induction of TRAIL-mediated glioma cell death by human T cells J. Neuroimmunol. 122 2002 117 124
-
(2002)
J. Neuroimmunol.
, vol.122
, pp. 117-124
-
-
Dörr, J.1
Waiczies, S.2
Wendling, U.3
Seeger, B.4
Zipp, F.5
-
6
-
-
0021915908
-
Pharmacokinetics and biotransformation of the analgesic flupirtine in humans
-
P. Hlavica, and G. Niebch Pharmacokinetics and biotransformation of the analgesic flupirtine in humans Arzneimittel-Forschung 35 1985 67 74
-
(1985)
Arzneimittel-Forschung
, vol.35
, pp. 67-74
-
-
Hlavica, P.1
Niebch, G.2
-
7
-
-
0034633769
-
Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS
-
W.X. Huang, M.P. Huang, M.A. Gomes, and J. Hillert Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS Neurology 55 2000 928 934
-
(2000)
Neurology
, vol.55
, pp. 928-934
-
-
Huang, W.X.1
Huang, M.P.2
Gomes, M.A.3
Hillert, J.4
-
8
-
-
0141861943
-
Losses of NG2 and NeuN immunoreactivity but not astrocytic markers during early reperfusion following severe focal cerebral ischemia
-
D.R. Lee, S.C. Helps, I.L. Gibbins, M. Nilsson, and N.R. Sims Losses of NG2 and NeuN immunoreactivity but not astrocytic markers during early reperfusion following severe focal cerebral ischemia Brain Res. 989 2003 221 230
-
(2003)
Brain Res.
, vol.989
, pp. 221-230
-
-
Lee, D.R.1
Helps, S.C.2
Gibbins, I.L.3
Nilsson, M.4
Sims, N.R.5
-
9
-
-
0037094010
-
Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells
-
J.D. Lunemann, S. Waiczies, S. Ehrlich, U. Wendling, B. Seeger, T. Kamradt, and F. Zipp Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells J. Immunol. 168 2002 4881 4888
-
(2002)
J. Immunol.
, vol.168
, pp. 4881-4888
-
-
Lunemann, J.D.1
Waiczies, S.2
Ehrlich, S.3
Wendling, U.4
Seeger, B.5
Kamradt, T.6
Zipp, F.7
-
10
-
-
0033562658
-
CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
-
A. Martin-Villalba, I. Herr, I. Jeremias, M. Hahne, R. Brandt, J. Vogel, J. Schenkel, T. Herdegen, and K.M. Debatin CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons J. Neurosci. 19 1999 3809 3817
-
(1999)
J. Neurosci.
, vol.19
, pp. 3809-3817
-
-
Martin-Villalba, A.1
Herr, I.2
Jeremias, I.3
Hahne, M.4
Brandt, R.5
Vogel, J.6
Schenkel, J.7
Herdegen, T.8
Debatin, K.M.9
-
11
-
-
0036846744
-
TRAIL induces death of human oligodendrocytes isolated from adult brain
-
M. Matysiak, A. Jurewicz, D. Jaskolski, and K. Selmaj TRAIL induces death of human oligodendrocytes isolated from adult brain Brain 125 2002 2469 2480
-
(2002)
Brain
, vol.125
, pp. 2469-2480
-
-
Matysiak, M.1
Jurewicz, A.2
Jaskolski, D.3
Selmaj, K.4
-
12
-
-
0037418333
-
Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection
-
Y. Miura, N. Misawa, Y. Kawano, H. Okada, Y. Inagaki, N. Yamamoto, M. Ito, H. Yagita, K. Okumura, H. Mizusawa, and Y. Koyanagi Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection Proc. Natl. Acad. Sci. U. S. A. 100 2003 2777 2782
-
(2003)
Proc. Natl. Acad. Sci. U. S. A.
, vol.100
, pp. 2777-2782
-
-
Miura, Y.1
Misawa, N.2
Kawano, Y.3
Okada, H.4
Inagaki, Y.5
Yamamoto, N.6
Ito, M.7
Yagita, H.8
Okumura, K.9
Mizusawa, H.10
Koyanagi, Y.11
-
13
-
-
0034596514
-
Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
-
R. Nitsch, I. Bechmann, R.A. Deisz, D. Haas, T.N. Lehmann, U. Wendling, and F. Zipp Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) Lancet 356 2000 827 828
-
(2000)
Lancet
, vol.356
, pp. 827-828
-
-
Nitsch, R.1
Bechmann, I.2
Deisz, R.A.3
Haas, D.4
Lehmann, T.N.5
Wendling, U.6
Zipp, F.7
-
14
-
-
0022004401
-
Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog
-
K. Obermeier, G. Niebch, and K. Thiemer Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog Arzneimittel-Forschung 35 1985 60 67
-
(1985)
Arzneimittel-Forschung
, vol.35
, pp. 60-67
-
-
Obermeier, K.1
Niebch, G.2
Thiemer, K.3
-
15
-
-
0028670691
-
The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1
-
S. Perovic, C. Schleger, G. Pergande, S. Iskric, H. Ushijima, P. Rytik, and W.E. Muller The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1 Eur. J. Pharmacol. 288 1994 27 33
-
(1994)
Eur. J. Pharmacol.
, vol.288
, pp. 27-33
-
-
Perovic, S.1
Schleger, C.2
Pergande, G.3
Iskric, S.4
Ushijima, H.5
Rytik, P.6
Muller, W.E.7
-
16
-
-
0030581738
-
Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: Mode of action of the drug-mediated anti-apoptotic effect
-
S. Perovic, P. Pialoglou, H.C. Schroder, G. Pergande, and W.E. Muller Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect Eur. J. Pharmacol. 317 1996 157 164
-
(1996)
Eur. J. Pharmacol.
, vol.317
, pp. 157-164
-
-
Perovic, S.1
Pialoglou, P.2
Schroder, H.C.3
Pergande, G.4
Muller, W.E.5
-
17
-
-
0031257755
-
Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126)
-
S. Perovic, H.C. Schroder, G. Pergande, H. Ushijima, and W.E. Muller Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126) Exp. Neurol. 147 1997 518 524
-
(1997)
Exp. Neurol.
, vol.147
, pp. 518-524
-
-
Perovic, S.1
Schroder, H.C.2
Pergande, G.3
Ushijima, H.4
Muller, W.E.5
-
18
-
-
0029558566
-
Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration
-
K. Rupalla, W. Cao, and J. Krieglstein Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration Eur. J. Pharmacol. 294 1995 469 473
-
(1995)
Eur. J. Pharmacol.
, vol.294
, pp. 469-473
-
-
Rupalla, K.1
Cao, W.2
Krieglstein, J.3
-
19
-
-
0032576752
-
Axonal transection in the lesions of multiple sclerosis
-
B.D. Trapp, J. Peterson, R.M. Ransohoff, R.A. Rudick, S. Mörk, and L. Bo Axonal transection in the lesions of multiple sclerosis N. Engl. J. Med. 338 1998 278 285
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 278-285
-
-
Trapp, B.D.1
Peterson, J.2
Ransohoff, R.M.3
Rudick, R.A.4
Mörk, S.5
Bo, L.6
-
20
-
-
12444304354
-
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis
-
K.P. Wandinger, J.D. Lünemann, O. Wengert, J. Bellmann-Strobl, O. Aktas, A. Weber, E. Grundstrom, S. Ehrlich, K.D. Wernecke, H.D. Volk, and F. Zipp TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis Lancet 361 2003 2036 2043
-
(2003)
Lancet
, vol.361
, pp. 2036-2043
-
-
Wandinger, K.P.1
Lünemann, J.D.2
Wengert, O.3
Bellmann-Strobl, J.4
Aktas, O.5
Weber, A.6
Grundstrom, E.7
Ehrlich, S.8
Wernecke, K.D.9
Volk, H.D.10
Zipp, F.11
-
21
-
-
0033933918
-
Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
-
U. Wendling, H. Walczak, J. Dörr, C. Jaboci, M. Weller, P.H. Krammer, and F. Zipp Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells Cell Death Differ. 7 2000 637 644
-
(2000)
Cell Death Differ.
, vol.7
, pp. 637-644
-
-
Wendling, U.1
Walczak, H.2
Dörr, J.3
Jaboci, C.4
Weller, M.5
Krammer, P.H.6
Zipp, F.7
-
22
-
-
13344285339
-
Identification and characterization of a new member of the TNF family that induces apoptosis
-
S.R. Wiley, K.A. Schooley, P.J. Smolak, W.S. Din, C.P. Huang, J.K. Nicholl, G.R. Sutherland, T.D. Smith, C.T. Rauch, C.A. Smith, and R.G. Goodwin Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
-
(1995)
Immunity
, vol.3
, pp. 673-682
-
-
Wiley, S.R.1
Schooley, K.A.2
Smolak, P.J.3
Din, W.S.4
Huang, C.P.5
Nicholl, J.K.6
Sutherland, G.R.7
Smith, T.D.8
Rauch, C.T.9
Smith, C.A.10
Goodwin, R.G.11
|